The Cancer Research Institute invites applications for its technology impact award. This supports the development of innovative technologies that can lead to the next generation personalised cancer immunotherapies.
The programme aims to encourage projects that generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modelling systems, immunological or tumour profiling instrumentation, methods, reagents and assays or other relevant technologies that can help clinician scientists gain deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.
Funding & Duration
Grants are worth up to USD $200,000 (approx. AUD $273,000) each for between one and two years.
Applications are open to individual investigators leading a cross-functional team. They must hold a faculty appointment as a tenure-track assistant professor, or higher rank, at the time of award activation.
Submission Requirements & Due Dates
- 15 November 2018 – Letter of Intent (LOI) submitted to Sponsor.
- 8 April 2019 – invited applications submitted for internal review.
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review